Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Medical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orthopedic, cardiovascular, cerebrovascular, dermatology, pediatrics, respiratory, nutritional supplements, and anesthesiology. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, and Shenqi Hypoglycemic capsules. The company also engages in industrial and real estate investment; technology research and development; ecological agriculture; and high-tech activities. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is headquartered in Xinyang, China.
Research context
Henan Lingrui Pharmaceutical Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Henan Lingrui Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 12.6% above its 200 day moving average.
From a valuation standpoint, the stock is 77.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Henan Lingrui Pharmaceutical Co., Ltd's total revenue rose by 10.1% to $575M since the same quarter in the previous year.
Its net income has increased by 17.7% to $92M since the same quarter in the previous year.
Finally, its free cash flow grew by 36.8% to $115M since the same quarter in the previous year.
Based on the above factors, Henan Lingrui Pharmaceutical Co., Ltd gets an overall score of 5/5.